Search Results

0 results for 'Eli Lilly'

You can use to get even better search results
March 26, 2024 | Corporate Counsel

TV Legal Ads Proving Useful Radar for Next Big Mass Tort Categories

Tracking television legal ads that solicit plaintiffs for mass torts can give general counsel early warning of new trends and gauge the plaintiffs' bar's appetite in product litigation categories.
5 minute read
March 19, 2024 | The Recorder

Despite Cuts, Fenwick Sees Revenue Growth and Remains Bullish on Tech Business Bounceback

"Some uncertainty remains. But it will come back, and come back stronger," said firm chair Richard Dickson about the firm's scope of work. "We just don't know exactly when."
5 minute read
March 15, 2024 | Law.com

Social Media Ads Inject New Angle in Ozempic Cases: 'It's Going to Be a Huge Focus'

The proliferation of advertising on social media for Ozempic and related drugs will be a key part of the lawsuits against Novo Nordisk and Eli Lilly.
6 minute read
March 15, 2024 | The Legal Intelligencer

Don't Be Cranky and Don't Cause Delays: Judge Pushes for Efficiency in Ozempic MDL

"What I want is to avoid asking for continuances and asking for delay and asking for new dates. Just pick your poison and stick with it," Pratter told the approximately 70 people gathered in her courtroom Thursday.
4 minute read
Law Journal Press | Digital Book Texas Legal Malpractice & Lawyer Discipline 2023 Authors: Charles F. Herring, JR, Jason M. Panzer, Leah Turner View this Book

View more book results for the query "Eli Lilly"

March 11, 2024 | Corporate Counsel

Weight-Loss-Drug Craze Pumps Up Pay for Lilly GC

Anat Hakim joined Lilly in 2020, just before the company's stock began a long ascent that has more than quadrupled its value—pushing the company's market capitalization past Tesla's.
2 minute read
March 06, 2024 | Corporate Counsel

Elanco Hires GC Just as Activist Investor Calls for CEO's Ouster

Shiv O'Neill's first high-stakes task will be helping the company navigate its relationship with Ancora Capital.
2 minute read
March 06, 2024 | National Law Journal

Finnegan, Recovering From Earlier Revenue Losses, Sees 6% Top-Line Growth

The firm has been investing in "adjacent services" that complement its traditional core IP offerings, said managing partner Erika Arner.
3 minute read
February 21, 2024 | Law.com

Treatment of Antibody Claims In the U.S. After 'Amgen v. Sanofi'

The future of antibody claiming in the United States is uncertain following the U.S. Supreme Court's ruling in 'Amgen Inc. v. Sanofi,' a highly anticipated decision concerning enablement and whether the traditional way to claim antibodies — claiming antibodies by their function — will survive as a valid claiming strategy.
8 minute read
February 09, 2024 | New Jersey Law Journal

Judge Rejects Class Action Claim Filed Against Novo Nordisk, Eli Lilly and Sanofi-Aventis

"Plaintiffs have not sufficiently shown they failed to receive the benefit of the bargain as they have not alleged that they had 'a reasonable belief about the product induced by a misrepresentation'—and in fact they have asserted the opposite, that their ascertainable loss theory is not based on misrepresentation—or that they were misled into buying insulin that was worth less than was promised," Judge Brian R. Martinotti said.
7 minute read

TRENDING STORIES

    Resources

    • The Ultimate Guide to Going Paperless for Law Firms

      Brought to you by Filevine

      Download Now

    • Top 10 Compliance Concerns for Private Fund Managers

      Brought to you by Ontra

      Download Now

    • The Top 10 Terms in Private Equity NDAs

      Brought to you by Ontra

      Download Now

    • 2024 Ethics & Compliance Program Effectiveness Report for North America

      Brought to you by LRN

      Download Now